The U.S. Food and Drug Administration approved Lipfendra (enlicitide), the first oral inhibitor of proprotein convertase subtilisin/kexin type 9 (PCSK9), as an adjunct to diet and exercise to reduce low-density lipoprotein cholesterol (LDL-C), or “bad” cholesterol, in adults with hypercholesterolemia, including those with heterozygous familial hypercholesterolemia...
The U.S. Food and Drug Administration recently announced the first manufacturer selected for the Technology-Enabled Meaningful Patient Outcomes (TEMPO) for Digital Health Devices Pilot. The participating manufacturer intends to offer a device for use in providing care expected to be covered by the Centers for Medicare & Medicaid Services (CMS) Innovation...
Gynecologic clear cell cancers are among the rarest and most difficult cancers to treat. They can develop in the ovaries or the lining of the uterus, called the endometrium, and they often don’t respond well once standard chemotherapy stops working. For many patients, treatment options become very limited if the cancer returns.
August is Autoinflammatory Disease Awareness Month, a time to learn about a group of rare conditions that can cause repeated episodes of inflammation throughout the body. Although these diseases are uncommon, they can have a major impact on the people who live with them.
LIFYORLI is prescribed in combination with nab-paclitaxel chemotherapy for adults with platinum-resistant epithelial ovarian, fallopian tube, or primary peritoneal cancer who have already received one to three prior systemic treatment regimens, including at least one that contained bevacizumab
What if one of the best ways to support your brain started with what’s on your plate? A recent review looked at the research on diet and Alzheimer’s disease and found that healthy eating patterns like the Mediterranean diet, the DASH diet, and the MIND diet are linked to a lower risk of cognitive decline and Alzheimer’s disease.